Boston Heart Diagnostics Corporation, a pioneer in integrating next-generation diagnostics with personal nutrition and lifestyle programs for patients with or at risk for heart disease, has received $1.0 million in additional tax incentives through the Life Sciences Tax Incentive Program. The company has pledged to create a minimum of 50 new Massachusetts jobs in 2014. Boston Heart was one of just 33 companies to receive the tax incentive through the program this year, which is jointly administered by the Massachusetts Life Sciences Center (MLSC) and the Massachusetts Department of Revenue. Excluding the latest award, Boston Heart has received more than $1.1 million in tax incentives from the MLSC program over the last three years. During that period, the company exceeded its pledge to create 102 Massachusetts full-time-equivalent (FTE) jobs, adding a total of 190 Massachusetts-based positions.
"Boston Heart is a Massachusetts success story and the Life Sciences Tax Incentive Program continues to be an important contributor to our achievements," said Boston Heart President and CEO, Susan Hertzberg. "These funds have helped us accelerate growth and enabled recruitment of our talented employees who are dedicated to improving the lives of patients. We continue to innovate, expand our portfolio of diagnostic and service offerings, and increase our reach in the market. We work with healthcare providers nationwide – giving them the tools they need to identify risk, individualize treatment plans, and engage patients in preventing and reversing cardiovascular disease. We greatly appreciate the support that MLSC provides in helping us to achieve our mission."
Study links heart shape to genetic risk of cardiovascular diseases